Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia

This publication has 6 references indexed in Scilit:

• Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis
  Experimental & Molecular Medicine, 2004
• Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis
  European Journal of Neurology, 2002
• EXPRESSION OF SOLUBLE CD137 CORRELATES WITH ACTIVATION-INDUCED CELL DEATH OF LYMPHOCYTES
  Cytokine, 2000
• A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis
  European Journal of Immunology, 1998
• Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP.
  The Journal of Experimental Medicine, 1995
• Immunophenotype analysis of B‐CLL lymphoma and immunocytoma
  APMIS, 1989